Search for: "NOVARTIS AG" Results 141 - 160 of 440
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Feb 2012, 9:38 pm
The drug is prescribed for attention deficit disorder and is manufactured by Novartis AG. [read post]
30 Aug 2011, 5:18 am by Lawrence B. Ebert
Teva, the world's largest generic drug company, won a court battle in SDNY in its role as a proprietary drug company making Copaxone, against Novartis AG's Sandoz unit, Momenta Pharmaceuticals Inc., Mylan Inc., and Natco Pharma Ltd. [read post]
1 Oct 2010, 3:38 am by traceydennis
Court of Appeal (Civil Division) Novartis AG & Anor v Johnson & Johnson Medical Ltd & Anor [2010] EWCA Civ 1039 (29 September 2010) High Court (Administrative Court) MXL, R (on the application of) & Ors v Secretary of State for the Home Department [2010] EWHC 2397 (Admin) (30 September 2010) High Court (Chancery Division) Anfield (UK) Ltd v Bank of Scotland Plc & Ors [2010] EWHC 2374 (Ch) (24 September 2010) Shepherd v Williamson & Anor [2010] EWHC 2375… [read post]
17 Feb 2010, 9:33 am by michael
Supreme Court Tomlinson & Ors v Birmingham City Council [2010] UKSC 8 (17 February 2010) Court of Appeal (Civil Division) Harley & Ors v Smith & Anor [2010] EWCA Civ 78 (17 February 2010) Actavis UK Ltd v Novartis AG [2010] EWCA Civ 82 (17 February 2010) Davies & Anor, R (on the application of) v HM Revenue & Customs [2010] EWCA Civ 83 (16 February 2010) Virdi v The Law Society of England and Wales & Anor [2010] EWCA Civ 100 (16 February 2010) Smith v Youth… [read post]
10 Jan 2012, 7:44 am by KGW Injury News
The FDA warns of just such a problem at the Novartis AG manufacturing plant in Nebraska, according to the Wall Street Journal from January 10, 2012. [read post]
25 Apr 2013, 5:02 pm
Plaintiff Dottie Dodson is suing Novartis AG for dangerous drug injury compensation. [read post]
30 Aug 2014, 5:03 am by Lawrence B. Ebert
In PARADIGM-HF the average age was 64 years old, considerably younger than the typical patient with heart failure. [read post]
7 Sep 2011, 3:53 am by Robert Kraft
The Wall Street Journal reports that the Food and Drug Administration has updated a warning regarding kidney failure and use of Novartis’ Reclast (zoledronic acid). [read post]
18 Dec 2009, 9:59 am by Karen E. Keller
(patent infringement) 12/10: Seattle Children's Hospital, Novartis AG, Novartis Vaccines and Diagnostics, Inc. and Novartis Pharmaceuticals Corporation v. [read post]
Pacific REGISTER HERE Join Seyfarth attorneys Dean Fanelli, Dawn Mertineit, and Kate Perrelli, along with in-house counsel Julie McCarthy, General Counsel and Vice-President of Legal Genomics Institute of the Novartis Research Foundation, for a webinar about defining and protecting trade secrets in the pharmaceutical industry. [read post]
23 May 2010, 10:46 am
In this age of government regulation and strict enforcement policies, the jury verdict is a wake-up call to companies who ignore, condone, or encourage sex discrimination at the workplace. [read post]
1 Jul 2020, 2:02 pm by Tom Lamb
We begin with this June 9, 2020 news report, "Review committee confirms safety signal of rare adverse events for Beovu", from which we get these insights: Novartis received reports of vasculitis in 14 patients treated for wet age-related macular degeneration with Beovu (brolucizumab-dbll) since its approval by the FDA in October 2019. [read post]
24 Oct 2017, 9:59 pm by Patent Docs
Novartis AG PTAB Petition: IPR2017-01929; filed August 16, 2017. [read post]
19 Jan 2022, 12:57 pm by Tom Lamb
Here are some details about the "risk factors" for those Beovu vision loss side effects from the so-called "Dear Doctor" letter about Beovu that Novartis UK sent on November 2, 2021, to healthcare professionals in the UK: Risk factors identified Novartis conducted non‐interventional retrospective real‐world evidence studies in patients with neovascular (wet) age‐related macular degeneration (nAMD) to better understand the incidence of… [read post]
26 Jul 2013, 7:48 am by Pilar G. Kraman
Plaintiffs previously filed a first amended complaint, and then a supplemental complaint adding Novartis Pharma AG, exclusive licensee of the patent-in-suit, as a co-plaintiff. [read post]
5 Jul 2006, 4:13 pm
Food and Drug Administration said on Monday that product labels for three popular asthma medications have been updated to state that the drugs could increase the chance of severe asthma attacks that could result in death.The warnings, first proposed last November, involve long-acting bronchodilator medicines Advair and Serevent, made by GlaxoSmithKline Plc, and Foradil from Novartis AG.In a public health advisory issued on its Web site, the FDA said the inhaled drugs should only be used… [read post]
7 Feb 2012, 7:05 am
Novartis plans to cut 1,630 sales positions in the field and about 330 positions at its New Jersey headquarters. [read post]